For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

The vaccine production process itself can be divided ... In addition to developing and manufacturing cutting-edge vaccines, GSK is committed to the role it plays, together with stakeholders ...

GSK has made another investment in its manufacturing network ... digital twins for continuous process optimisation, robotics for material handling, and predictive maintenance and digital ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines ...

She is currently working for GSK within their Global Supply Chain Engineering and EHS compliance ... Chartered Engineer with experience in a variety of pharmaceutical engineering roles across R&D and ...

GSK said the vast majority of the products will be for export to global markets, adding that the investment builds on the company’s existing network of nine UK manufacturing sites, employing ...

This year’s honorees, Boehringer Ingelheim and GSK, have set new standards in sustainable manufacturing. Boehringer Ingelheim’s team created a highly efficient 3-step synthesis for Spiroketone CD 7659 ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and ...

SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850 million ...

Working out of 12 manufacturing sites, the company distributed 767 million vaccine doses across more than 160 countries in 2021. More than ten million people received one of GSK’s meningococcal ...